Event-related potentials and mild cognitive impairment in Parkinson’s disease.
Objective: To measure N170, P3a/P3b peak amplitudes and latencies in PD with (PD-MCI) and without (PD-NC) mild cognitive impairment and to correlate them with clinical-demographic, neuropsychological and…Information Content of Spoken Language in Parkinson’s Disease Without Dementia
Objective: Investigate differences in spoken language content in Parkinson’s disease (PD) compared to older controls. Background: Conveying information is a primary goal of communication. PD language…Altered attentional brain network in Parkinson’s disease with mild cognitive impairment
Objective: To investigate alterations in the attention network in Parkinson’s disease patients with mild cognitive impairment (PD-MCI). Background: MCI is a risk factor for dementia…Increased hippocampal activation in Parkinson’s disease related amnestic mild cognitive impairment
Objective: To assess the functional significance of hippocampal network dysfunction in Parkinson’s disease related amnestic mild cognitive impairment (PD aMCI) using high-resolution functional neuroimaging. Background:…APOE4+ status increases rate of longitudinal cognitive decline in Parkinson Disease patients with low CSF Aβ42
Objective: To determine if the presence of APOEɛ4 allele (APOE4+) predicts longitudinal cognitive decline in Parkinson’s disease (PD) patients with low CSFAβ42 Background: Cognitive impairment…Olfactory deficits in the cognitive impaired de novo patients with Parkinson’s disease
Objective: To determine whether olfactory deficits may be related to the cognitive impairment in de novo Parkinson’s disease patients. Background: Hyposmia is highly prevalent in…Quantitative measures of brain MRI as a predictive factor of cognitive outcomes after Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s disease
Objective: To explore whether pre-surgical white matter lesion volume, measured quantitatively on brain MR images, is predictive of cognitive outcomes following subthalamic nucleus deep brain…Clinical Experience with Initiation of Carbidopa/Levodopa Enteral Suspension in Parkinson’s Disease Patients with Cognitive Impairment
Objective: To assess the safety and efficacy of carbidopa/levodopa enteral suspension (CLES) in Parkinson’s disease (PD) patients with cognitive impairment. Background: As Parkinson’s Disease progresses,…Rapidly progressive dementia and parkinsonism caused by a cortical dural AV fistula: a case report
Objective: To report the case of a 75-year-old woman with rapidly progressive dementia and parkinsonism caused by a cortical dural AV fistula Background: Vascular malformations…Predict cognitive decline with non-clinical markers in Parkinson’s disease
Objective: In this study, we investigated whether [123I]FP-CIT single photon emission computed tomography (SPECT) imaging measures and CSF marker profiles predict CI in PD patients…
- « Previous Page
- 1
- …
- 110
- 111
- 112
- 113
- 114
- …
- 141
- Next Page »